One more chance of fistula healing in inflammatory bowel disease: Stem cell therapy

Patients with fistulizing inflammatory bowel disease are traditionally difficult to treat. This patient population often experiences delayed or insufficient healing of fistulas using current standard regimens including antibiotics, immunomodulators, anti-tumor necrosis factor-α drug, placement of se...

Descripción completa

Detalles Bibliográficos
Autores principales: Turse, Erica P, Dailey, Francis E, Naseer, Maliha, Partyka, Edward K, Tahan, Veysel
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Baishideng Publishing Group Inc 2018
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6212615/
https://www.ncbi.nlm.nih.gov/pubmed/30397605
http://dx.doi.org/10.12998/wjcc.v6.i12.493

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6212615/
https://www.ncbi.nlm.nih.gov/pubmed/30397605
http://dx.doi.org/10.12998/wjcc.v6.i12.493

Ejemplares similares